![David Canner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Canner
Directeur/Membre du Conseil chez
INHIBIKASE THERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
David Canner is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024.
Dr. Canner is also a Partner at Soleus Capital LLC since 2018.
Dr. Canner holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de David Canner
| Sociétés | Poste | Début |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/10/2024 |
Soleus Capital LLC | Corporate Officer/Principal | 01/01/2018 |
Formation de David Canner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Soleus Capital LLC |
